Holdings (Monthly)
Guide ↗
Franklin Biotechnology Discovery Fund
· Franklin Strategic Series| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 375558103 | Jan 2026 | 443,663 | $63.0M | 6.18% | EC |
| 2 | Amgen, Inc. | 031162100 | Jan 2026 | 143,458 | $49.0M | 4.81% | EC |
| 3 | Vertex Pharmaceuticals, Inc. | 92532F100 | Jan 2026 | 102,150 | $48.0M | 4.71% | EC |
| 4 | Jazz Pharmaceuticals plc | N/A | Jan 2026 | 283,073 | $46.6M | 4.57% | EC |
| 5 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Jan 2026 | 61,019 | $45.2M | 4.44% | EC |
| 6 | Argenx SE | 04016X101 | Jan 2026 | 48,962 | $41.2M | 4.04% | EC |
| 7 | Franklin Institutional U.S. Government Money Market Fund | 8611239C3 | Jan 2026 | 35,318,834 | $35.3M | 3.47% | STIV |
| 8 | Praxis Precision Medicines, Inc. | 74006W207 | Jan 2026 | 104,696 | $32.9M | 3.23% | EC |
| 9 | Insmed, Inc. | 457669307 | Jan 2026 | 188,633 | $29.6M | 2.91% | EC |
| 10 | Ascendis Pharma A/S | 04351P101 | Jan 2026 | 129,742 | $29.3M | 2.88% | EC |
| 11 | Guardant Health, Inc. | 40131M109 | Jan 2026 | 248,985 | $28.4M | 2.79% | EC |
| 12 | PTC Therapeutics, Inc. | 69366J200 | Jan 2026 | 369,527 | $27.9M | 2.74% | EC |
| 13 | Terns Pharmaceuticals, Inc. | 880881107 | Jan 2026 | 770,542 | $26.7M | 2.62% | EC |
| 14 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Jan 2026 | 66,908 | $22.6M | 2.22% | EC |
| 15 | Mirum Pharmaceuticals, Inc. | 604749101 | Jan 2026 | 215,190 | $22.2M | 2.18% | EC |
| 16 | Revolution Medicines, Inc. | 76155X100 | Jan 2026 | 202,430 | $19.6M | 1.93% | EC |
| 17 | Mineralys Therapeutics, Inc. | 603170101 | Jan 2026 | 623,239 | $19.3M | 1.89% | EC |
| 18 | AstraZeneca plc | 046353108 | Jan 2026 | 205,062 | $19.0M | 1.87% | EC |
| 19 | Neurocrine Biosciences, Inc. | 64125C109 | Jan 2026 | 135,273 | $18.4M | 1.81% | EC |
| 20 | Abivax SA | 00370M103 | Jan 2026 | 164,591 | $18.3M | 1.80% | EC |
| 21 | EyePoint, Inc. | 30233G209 | Jan 2026 | 1,269,215 | $17.2M | 1.68% | EC |
| 22 | Structure Therapeutics, Inc. | 86366E106 | Jan 2026 | 192,930 | $17.1M | 1.68% | EC |
| 23 | Ionis Pharmaceuticals, Inc. | 462222100 | Jan 2026 | 205,400 | $17.0M | 1.67% | EC |
| 24 | Bridgebio Pharma, Inc. | 10806X102 | Jan 2026 | 207,858 | $16.1M | 1.58% | EC |
| 25 | Eli Lilly & Co. | 532457108 | Jan 2026 | 14,071 | $14.6M | 1.43% | EC |
| 26 | Olema Pharmaceuticals, Inc. | 68062P106 | Jan 2026 | 560,230 | $14.4M | 1.41% | EC |
| 27 | Arcutis Biotherapeutics, Inc. | 03969K108 | Jan 2026 | 505,651 | $12.8M | 1.26% | EC |
| 28 | Benitec Biopharma, Inc. | 08205P209 | Jan 2026 | 995,152 | $12.1M | 1.19% | EC |
| 29 | Syndax Pharmaceuticals, Inc. | 87164F105 | Jan 2026 | 579,788 | $11.8M | 1.16% | EC |
| 30 | CG oncology, Inc. | 156944100 | Jan 2026 | 221,481 | $11.5M | 1.13% | EC |
| 31 | Dianthus Therapeutics, Inc. | 252828108 | Jan 2026 | 203,063 | $10.8M | 1.06% | EC |
| 32 | Centessa Pharmaceuticals plc | 152309100 | Jan 2026 | 424,429 | $10.4M | 1.02% | EC |
| 33 | Dyne Therapeutics, Inc. | 26818M108 | Jan 2026 | 519,232 | $9.3M | 0.91% | EC |
| 34 | ARS Pharmaceuticals, Inc. | 82835W108 | Jan 2026 | 901,810 | $9.0M | 0.88% | EC |
| 35 | Franklin Institutional U.S. Government Money Market Fund | 457756500 | Jan 2026 | 8,793,093 | $8.8M | 0.86% | STIV |
| 36 | Oruka Therapeutics, Inc. | 687604108 | Jan 2026 | 249,964 | $8.6M | 0.84% | EC |
| 37 | Nuvalent, Inc. | 670703107 | Jan 2026 | 75,535 | $7.8M | 0.76% | EC |
| 38 | Spyre Therapeutics, Inc. | 00773J202 | Jan 2026 | 220,000 | $7.0M | 0.69% | EC |
| 39 | Soleno Therapeutics, Inc. | 834203309 | Jan 2026 | 181,503 | $7.0M | 0.69% | EC |
| 40 | Achieve Life Sciences, Inc. | 004468500 | Jan 2026 | 1,575,682 | $6.6M | 0.65% | EC |
| 41 | Bicara Therapeutics, Inc. | 055477103 | Jan 2026 | 387,402 | $6.5M | 0.64% | EC |
| 42 | Amylyx Pharmaceuticals, Inc. | 03237H101 | Jan 2026 | 439,918 | $6.3M | 0.62% | EC |
| 43 | uniQure NV | N/A | Jan 2026 | 270,640 | $6.1M | 0.60% | EC |
| 44 | Newamsterdam Pharma Co. NV | N/A | Jan 2026 | 187,726 | $5.8M | 0.57% | EC |
| 45 | Tango Therapeutics, Inc. | 87583X109 | Jan 2026 | 491,884 | $5.7M | 0.56% | EC |
| 46 | Spyre Therapeutics, Inc. | 00773J202 | Jan 2026 | 176,281 | $5.6M | 0.55% | EC |
| 47 | Inventiva SACA | 46124U107 | Jan 2026 | 908,000 | $5.6M | 0.55% | EC |
| 48 | Contineum Therapeutics, Inc. | 21217B100 | Jan 2026 | 381,063 | $5.4M | 0.53% | EC |
| 49 | Apogee Therapeutics, Inc. | 03770N101 | Jan 2026 | 82,737 | $5.4M | 0.53% | EC |
| 50 | ORIC Pharmaceuticals, Inc. | 68622P109 | Jan 2026 | 524,519 | $5.4M | 0.53% | EC |
| 51 | Xenon Pharmaceuticals, Inc. | 98420N105 | Jan 2026 | 123,767 | $5.1M | 0.50% | EC |
| 52 | Thermo Fisher Scientific, Inc. | 883556102 | Jan 2026 | 8,579 | $5.0M | 0.49% | EC |
| 53 | LENZ Therapeutics, Inc. | 52635N103 | Jan 2026 | 312,267 | $4.9M | 0.48% | EC |
| 54 | BeOne Medicines Ltd. | 07725L102 | Jan 2026 | 14,276 | $4.9M | 0.48% | EC |
| 55 | Centessa Pharmaceuticals plc | 152309100 | Jan 2026 | 189,736 | $4.7M | 0.46% | EC |
| 56 | Zealand Pharma A/S | N/A | Jan 2026 | 69,700 | $4.7M | 0.46% | EC |
| 57 | Solid Biosciences, Inc. | 83422E204 | Jan 2026 | 711,882 | $4.6M | 0.45% | EC |
| 58 | GRAIL, Inc. | 384747101 | Jan 2026 | 46,433 | $4.5M | 0.45% | EC |
| 59 | Aura Biosciences, Inc. | 05153U107 | Jan 2026 | 765,617 | $4.3M | 0.42% | EC |
| 60 | Contineum Therapeutics, Inc. | 21217B100 | Jan 2026 | 295,058 | $4.2M | 0.41% | EC |
| 61 | Phathom Pharmaceuticals, Inc. | 71722W107 | Jan 2026 | 285,271 | $3.9M | 0.38% | EC |
| 62 | Context Therapeutics, Inc. | 21077P108 | Jan 2026 | 1,479,200 | $3.9M | 0.38% | EC |
| 63 | Benitec Biopharma, Inc. | N/A | Jan 2026 | 310,881 | $3.8M | 0.37% | EC |
| 64 | Alto Neuroscience, Inc. | 02157Q109 | Jan 2026 | 240,205 | $3.7M | 0.37% | EC |
| 65 | Cytokinetics, Inc. | 23282W605 | Jan 2026 | 53,272 | $3.4M | 0.33% | EC |
| 66 | Palisade Bio, Inc. | 696389402 | Jan 2026 | 2,119,910 | $3.2M | 0.31% | EC |
| 67 | Structure Therapeutics, Inc. | 86366E106 | Jan 2026 | 34,633 | $3.1M | 0.30% | EC |
| 68 | Oruka Therapeutics, Inc. | 687604108 | Jan 2026 | 86,030 | $2.9M | 0.29% | EC |
| 69 | Lycia LLC | N/A | Jan 2026 | 859,370 | $2.8M | 0.28% | EC |
| 70 | Candid, Inc. | N/A | Jan 2026 | 1,519,609 | $2.7M | 0.27% | EC |
| 71 | Ideaya Biosciences, Inc. | 45166A102 | Jan 2026 | 81,852 | $2.6M | 0.26% | EC |
| 72 | Ultragenyx Pharmaceutical, Inc. | 90400D108 | Jan 2026 | 108,067 | $2.6M | 0.26% | EC |
| 73 | Engene Holdings, Inc. | N/A | Jan 2026 | 272,359 | $2.6M | 0.25% | EC |
| 74 | Sionna Therapeutics, Inc. | 829401108 | Jan 2026 | 60,891 | $2.6M | 0.25% | EC |
| 75 | Sartorius AG | N/A | Jan 2026 | 9,200 | $2.6M | 0.25% | EP |
| 76 | Alto Neuroscience, Inc. | 02157Q109 | Jan 2026 | 165,070 | $2.6M | 0.25% | EC |
| 77 | Verastem, Inc. | 92337C203 | Jan 2026 | 401,744 | $2.5M | 0.24% | EC |
| 78 | Sartorius Stedim Biotech | N/A | Jan 2026 | 10,100 | $2.3M | 0.22% | EC |
| 79 | Palisade Bio, Inc. | 696389154 | Jan 2026 | 1,447,549 | $2.2M | 0.21% | — |
| 80 | Acumen Pharmaceuticals, Inc. | 00509G209 | Jan 2026 | 826,400 | $2.1M | 0.21% | EC |
| 81 | Immix Biopharma, Inc. | 45258H106 | Jan 2026 | 357,034 | $2.1M | 0.20% | EC |
| 82 | Engene Holdings, Inc. | 29286M105 | Jan 2026 | 214,220 | $2.0M | 0.20% | EC |
| 83 | Adicet Bio, Inc. | 007002207 | Jan 2026 | 225,186 | $1.8M | 0.18% | EC |
| 84 | BioAge Labs, Inc. | 09077V100 | Jan 2026 | 90,709 | $1.7M | 0.17% | EC |
| 85 | Vicore Pharma Holding AB | N/A | Jan 2026 | 1,307,598 | $1.6M | 0.16% | EC |
| 86 | Achieve Life Sciences, Inc. | N/A | Jan 2026 | 698,900 | $1.1M | 0.11% | — |
| 87 | Satellos Bioscience, Inc. | 80401L803 | Jan 2026 | 1,161,960 | $1.1M | 0.11% | EC |
| 88 | Cardiff Oncology, Inc. | 14147L108 | Jan 2026 | 438,961 | $768K | 0.08% | EC |
| 89 | Assembly Biosciences, Inc. | 045396207 | Jan 2026 | 29,620 | $763K | 0.07% | EC |
| 90 | Artiva Biotherapeutics, Inc. | 04317A107 | Jan 2026 | 192,871 | $750K | 0.07% | EC |
| 91 | IN8bio, Inc. | 45674E208 | Jan 2026 | 332,083 | $654K | 0.06% | EC |
| 92 | Carmot Therapeutics, Inc. | N/A | Jan 2026 | 83,100 | $532K | 0.05% | EC |
| 93 | Assembly Biosciences, Inc. | N/A | Jan 2026 | 44,450 | $487K | 0.05% | EC |
| 94 | IN8bio, Inc. | N/A | Jan 2026 | 69,673 | $34K | 0.00% | — |
| 95 | Assembly Biosciences, Inc. | N/A | Jan 2026 | 44,450 | $31K | 0.00% | EC |
| 96 | Nuvation Bio, Inc. | 67080N119 | Jan 2026 | 115,266 | $4K | 0.00% | — |
| 97 | Danish Krone | N/A | Jan 2026 | 740 | $117 | 0.00% | STIV |
| 98 | Sanofi SA | N/A | Jan 2026 | 2,333,755 | $0 | 0.00% | EC |